http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#head http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#provenance http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/3439 http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0019196 http://rdf.disgenet.org/resource/gda/DGN0b5d84a7c1ea4fee237678f8cbf05b7d http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#provenance http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://purl.org/dc/terms/description [To determine whether baseline LDL or HDL levels and statin use affect SVR rates, we retrospectively evaluated the IDEAL (Individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) trial, in which 3070 treatment-naive, hepatitis C virus (HCV) genotype 1-infected patients were treated for up to 48 weeks in one of the following arms: (1) peginterferon (PEG-IFN) alfa-2b at 1.5 microg/kg/week with ribavirin (RBV) at 800 to 1400 mg/day, (2) PEG-IFN alfa-2b at 1.0 microg/kg/week with RBV at 800 to 1400 mg/day, or (3) PEG-IFN alfa-2a at 180 microg/week with RBV at 1000 to 1200 mg/day.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/20568303 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/dc/terms/created 2017-10-17T13:13:35+02:00 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP535706.RAJiyfAAo8ghdx37NAYIB4qeQkXFLJgTafOofXK2hiBeI http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0